Is hormone therapy still a valid option? 12 ObGyns address this question
Clinicians understand the risks and benefits of hormone therapy for menopausal women more precisely than ever—but has the pendulum swung too far in the direction of risk?
IN THIS ARTICLE
Saul R. Berg, MD
Pittsburgh, Pa
I believe that the tide will turn in regard to HT in the not-too-distant future. It takes time for the real truth to get out. In the meantime, scare headlines tend to grab attention.
I hope that, in the near future, we will be able to genetically identify women who should not use HT. Until then, I discuss the risks and benefits of HT with my patients and honor their decision. Transdermal estrogen and bimonthly or quarterly progestin—I typically use Prometrium—are my preference.
At present, there don’t seem to be any outstanding alternatives to hormonal therapy.
Dr. Berg reports no relevant financial relationships.
INSTANT POLL
How do you counsel and treat your menopausal patients who report bothersome vasomotor symptoms?
To enter your response, click here.
We want to hear from you! Tell us what you think.
